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 Intense stress can challenge tissue homeostasis and accelerate the ageing process.
However, several lines of evidence indicate that repeated mild stresses can have beneficial
and even life-prolonging effects. Hypersecretion of glucocorticoids (GC) represents the
major hormonal response to stress. Besides its life-sustaining role, GC excess, usually due
to several side-effects that promote a “catabolic” phenotype, can be detrimental for sever-
al tissues. Cushing’s syndrome patients are characterized by chronic endogenous GC
excess and consequently at the time of diagnosis they have an atrophic elderly-like skin.
Interestingly, when Cushing’s syndrome fibroblasts were removed from the high-GC
milieu in vivo and cultured in vitro under standard conditions they express an “anabolic”
phenotype, i.e. they restore their ability for collagen synthesis, they secrete reduced levels
of metalloproteases (MMP-1 and MMP-2) and have an increased proliferative capacity and
contractility. Furthermore, these cells exhibit a significant extension of their proliferative
lifespan, while they respond better to exogenous stress by producing significantly higher
levels of heat-shock protein-70 (HSP70). These results imply that long-term hypercorti-
solism in vivo can have beneficial consequences on fibroblast physiology in vitro.
Keywords: hormesis, longevity, glucocorticoids, Cushing’s syndrome, proliferation, stress
INTRODUCTION
Ageing represents a failure in tissue homeostasis, in both mainte-
nance and repair processes. At the cellular level, it is now well known that
normal cells have only a limited lifespan, i.e. when cultured in vitro they
can undergo only a limited number of population doublings before they
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stop proliferating and enter a so-called “senescent” state (Smith and
Lincoln 1984; Kletsas 2003). Senescent fibroblasts exhibit an altered phe-
notype, i.e. they are enlarged, flattened, irregular in shape, with large lob-
ulated nuclei, and increased number of vacuoles and lysosomal granules
(Kletsas 2003). Furthermore, they display major alterations in functional
characteristics, beyond their inability to proliferate. DNA microarray
analysis has revealed that senescent fibroblasts exhibit a “pro-inflamma-
tory” phenotype, e.g. they suppress collagen synthesis and they express
increased levels of metalloproteases, inflammatory cytokines or other
pro-inflammatory molecules, such as ICAM-1 (Shelton et al. 1999;
Gorgoulis et al. 2005). Due to this phenotype, it is believed that the accu-
mulation of senescent cells in the tissues during ageing contributes to the
ageing process and the development of age-related diseases (Hornsby
2002). Especially, in the connective tissue such as in skin, ageing is lead-
ing to the thinning of the dermis (Lavker et al. 1989) and in a decreased
ability for wound healing (Gerstein et al. 1993).
It is generally believed that chronic or intense exogenous stresses are
able to accelerate the ageing process. At the cellular level, extreme – still
non-lethal – stresses, such as treatment with H2O2, tert-butylhydroperox-
ide, ethanol or UV light, can lead to a stress-induced premature senes-
cence (SIPS) (Toussaint et al. 2002). The stress-induced senescent cells
are in many aspects similar, although not identical, to the cells that
became senescent by successive replications (replicative senescence). On
the other hand, repeated treatments with mild stresses, such as heat or
cold shock, mild irradiation, hypergravity, exercise etc. has been report-
ed to generate anti-ageing or even life-prolonging effects at the cellular
or organismal level (Minois 2000; Rattan 2001), representing another
example of “hormesis” (Calabrese and Baldwin 2000). However, the pos-
sibility that stress hormones-that regulate the stress response at the level
of whole organism-can have such a dual role has not been studied so far. 
Cortisol hypersecretion, as a result of the activation of the hypothala-
mic-pituitary-adrenal (HPA) axis, is one of the primary hormonal
responses to stress. Although a short-term cortisol excess elicits a life-sus-
taining role, chronic exposure to glucocorticoids (GC) is responsible for
a variety of adverse effects in several cell types (Munck et al. 1984).
Indeed, chronic GC excess, either exogenous, as a part of treatment
regimes, or endogenous, as a result of chronic stress, has severe detri-
mental effects in almost all tissues (Boumpas et al. 1993; Boscaro et al.
2001). In addition, it has been suggested that GCs may accelerate the age-
ing process (Sapolsky 1996). The skin is one of the tissues most pro-
foundly affected by glucocorticoid excess, leading to atrophy and
impaired wound healing (Sowers and Lippman 1985; Oikarinen and
Autio 1991; Boscaro et al. 2001), a state reminiscent of the aged skin.
These detrimental effects of GCs in skin are mediated primarily by inter-
H. Pratsinis and others
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ferences with skin fibroblasts’ function. In particular, in vitro studies have
shown that GCs induce profound alterations on several parameters of
extracellular matrix (ECM) homeostasis, such as a decrease in collagen
synthesis and an altered expression of matrix metalloproteinases
(MMPs), leading finally to a reduction of the collagen mass (Autio et al.
1994; Slavin et al. 1994; Oikarinen et al. 1998). In general, increased
(pharmacological) doses of GCs induce a “catabolic” phenotype in skin
fibroblasts in vivo and in vitro. 
Endogenous Cushing’s syndrome is a rare disease due to cortisol over-
production by the adrenal glands (Orth 1995). Most patients have
atrophic skin and impaired wound healing. Skin fibroblasts from these
individuals therefore represent a model suitable for the investigation in
vitro of the cumulative effects of prior exposure to elevated (non-phar-
macological) glucocorticoid levels in the absence of an exogenous stress.
In an effort to understand if this exposure may affect – negatively or pos-
itively – several aspects of tissue homeostasis, primary cultures of skin
fibroblasts obtained from patients suffering from endogenous Cushing’s
syndrome (Cushing Fibroblasts: CF) have been developed and their func-
tional characteristics when grown under standard culture conditions in
vitro in the absence of exogenous GC administration were studied. In par-
ticular, possible long-lasting alterations concerning central fibroblast
activities involved in skin homeostasis and wound repair, such as prolifer-
ation, contraction, production and degradation of extracellular matrix
components, as well as cellular longevity, were investigated – in compari-
son to skin fibroblasts from normal donors (Normal Fibroblasts: NF).
COLLAGEN SYNTHESIS AND CATABOLISM IN CUSHING’S SYNDROME
FIBROBLASTS
Thinning of the dermis is one major feature of the aged skin (Lavker
et al. 1989). Collagen is the most abundant protein in the dermis and con-
sequently inhibition of its synthesis is a primary cause of dermal atrophy.
Furthermore, an increase in matrix metalloproteases (MMPs) secretion,
enhancing collagenolysis, could play equally important role in the dereg-
ulation of skin homeostasis. Indeed, a reduction in collagen synthesis and
an increase in the expression of matrix metalloproteases, has been found
during senescence (Khorramizadeh et al. 1999). Also treatment with glu-
cocorticoids has a “catabolic” effect in skin, similar to age-related alter-
ations. It is well known that exposure to glucocorticoids grossly diminish-
es type I procollagen synthesis at the mRNA and protein level in human
dermal fibroblasts (Cockayne et al. 1986; Slavin et al. 1994). This reduc-
tion is due to the coordinate action of GCs through both glucocorticoid-
and TGF-β- responsive elements (Meisler et al. 1995). When skin fibrob-
lasts from Cushing’s syndrome patients were removed from the high cor-
tisol milieu in vivo and cultured in vitro in the absence of cortisol they
Stress hormones and fibroblast longevity
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expressed comparable amounts of α1-procollagen mRNA with fibroblasts
from normal donors (authors’ personal unpublished data).
Furthermore, collagen synthesis, measured by the incorporation of triti-
ated proline in newly secreted collagen was restored to normal levels
(Table 1). In addition, when treated with TGF-β - a potent inducer of col-
lagen synthesis - Cushing’s and normal skin fibroblasts exhibited similar
stimulation of 3H-proline incorporation over control levels (Zervolea et
al. 2005). Even more, these cells were found to secrete significantly lower
levels of the metalloproteases MMP-1 and MMP-2, compared to normal
fibroblasts (Table 1). Regarding the tissue inhibitors of MMPs (TIMPs),
CF were found to secrete lower levels of TIMP-1 than NF, while there was
no significant difference in TIMP-2 levels (Table 1). 
CUSHING’S SYNDROME FIBROBLASTS EXHIBIT AN INCREASED 
PROLIFERATIVE CAPACITY AND CONTRACTILITY IN VITRO
It was further discovered that Cushing’s syndrome patients’ skin
fibroblasts can proliferate much faster, compared to cells from control
normal donors. This has been shown both by their increased ability to
synthesize DNA, a prerequisite for proliferation, and their shorter popu-
lation doubling time (Table 2). In addition, Cushing’s fibroblasts were
found to achieve much higher final cell densities than fibroblasts from
normal donors (Table 2). 
Contraction represents an important fibroblast function in normal
skin homeostasis, as well as in the wound healing process. Gels of poly-
merized collagen populated by fibroblasts provide a functional in vitro
model of tissue contraction (Grinnell 2000). Glucocorticoids, such as
H. Pratsinis and others
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TABLE 1: Extracellular Matrix Production & Catabolism by Cushing Fibroblasts
CF NF p
Collagen synthesis 4751 (± 383) 4240 (± 417) 0.631
[3H]Proline incorporation (CPM/105 cells)
MMP-1 secretion 30.4 (± 4.6) 55.4 (± 9.4) 0.010
Western analysis (A.U./ 104 cells)
MMP-2 activity 61.8 (± 2.4) 91.3 (± 5.3) 0.004
Gelatin zymography (A.U./ 104 cells)
TIMP-1 secretion 28.3 (± 5.4) 56.4 (±11.4) 0.037
Western analysis (A.U./ 104 cells)
TIMP-2 secretion 67.7 (± 8.9) 76.5 (± 9.2) 0.749
Western analysis (A.U./ 104 cells)
All parameters have been measured in conditioned media derived from arrested cultures of CF
and NF, as described in detail elsewhere (Zervolea et al. 2000; Zervolea et al. 2005). Median values (±
standard error) for each group (n=6) are presented; p was estimated by using the non-parametric
Mann and Whitney rank sum test. From Zervolea et al. (2005) Eur J Endocrinol 152: 895-902 ((c)
Society of the European Journal of Endocrinology (2005). Reproduced by permission).
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dexamethasone or hydrocortisone, can reduce skin fibroblast-mediated
contraction, and this effect may play a role in the delay in the wound-heal-
ing process (Gabbiani 1979; Coulomb et al. 1984). This inhibition is
reversed when Cushing’s fibroblasts are transferred in vitro and cultured
in the absence of glucocorticoids: collagen matrices populated by an
equal number of Cushing’s and normal fibroblasts were more intensely
contracted by the former compared to the latter (Table 2).
All the data presented above indicate that when skin fibroblast from
Cushing’s syndrome patients where removed from the high-cortisol
milieu and cultured in vitro under standard conditions, they restore their
ability for collagen production, they secrete lower levels of metallopro-
teases, and they exhibit an increased proliferative capacity, a higher final
cell culture density and an increased contractility. Collectively, these ana-
bolic responses are in clear contrast to the catabolic effects of glucocorti-
coids observed in vivo or in vitro and, indicate that prior chronic exposure
to glucocorticoid excess is not associated with a persisting adverse out-
come in the functional phenotype of these cells.
FIBROBLASTS FROM CUSHING’S SYNDROME PATIENTS EXHIBIT AN
INCREASED LIFESPAN IN VITRO
As mentioned above, Cushing’s syndrome patients have an elderly-
like skin. Given that skin fibroblasts derived from patients suffering from
age-related pathologies, e.g. diabetes, exhibit a shorter lifespan in vitro
(Cristofalo et al. 1998), the in vitro longevity of Cushing’s syndrome
fibroblasts was measured. Unexpectedly, these cells exhibit a near 40%
extension of their lifespan, compared to cells from sex- and age-matched
control donors (Figure 1).
The effect of increased cortisol concentrations on the longevity of
human fibroblasts has been already addressed, though with controversial
Stress hormones and fibroblast longevity
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TABLE 2: Proliferative & Contractile Characteristics of Cushing Fibroblasts
CF NF p
DNA synthesis rate 325 (± 49) 210 (± 39) 0.037
[3H]Thymidine incorporation (CPM/103 cells)
Doubling Time (hours) 28.3 (± 1.5) 33.9 (± 1.8) 0.055
Saturation cell density (103 cells/cm2) 114.5 (±12.7) 78.5 (± 7.0) 0.016
Collagen gel contraction 46.0 (± 1.1) 54.8 (± 3.1) 0.037
Gel diameter (% of initial diameter)
Proliferative characteristics of CF and NF cultured in the presence of 10% Fetal Bovine Serum,
and cell-populated collagen gel contraction were studied as described in detail elsewhere (Zervolea
et al. 2005). Median values (± standard error) for each group (n=6) are presented; p was estimated
by using the non-parametric Mann and Whitney rank sum test. From Zervolea et al. (2005) Eur J
Endocrinol 152: 895-902 ((c) Society of the European Journal of Endocrinology (2005). Reproduced
by permission).
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results. Early studies have shown a significant extension of the lifespan of
embryonic lung fibroblasts when cultured in the presence of cortisol
(Maciera-Coelho 1966; Grove and Cristofalo 1977; Nichols et al. 1977),
however, this has not been reproduced by other investigators, using a dif-
ferent protocol (Didinsky and Rheinwald 1981). The discrepancy
between the effect of increased cortisol concentrations in vivo and in vitro
can be due to the differences between the conditions under which the
cells are exposed to cortisol. For example, while in vitro the cells are pro-
liferating in the presence of serum and are exposed in a single dose of
cortisol, in the tissue in vivo they are quiescent in the absence of serum,
and they are exposed to cortisol in a definite diurnal rhythm, as well as in
other local or systemic factors. Indeed, other systemic factors-beyond cor-
tisol-that are also altered in Cushing’s syndrome could also be responsi-
ble for this phenomenon, such as growth hormone (GH) and Insulin-like
Growth Factor-I (IGF-I), which are drastically down-regulated in the plas-
ma of these patients (Wajchenberg et al. 1996; Unterman and Phillips
1985). In this vein, it has been reported that GH and IGF-I overexpres-
sion in transgenic mice leads to accelerated ageing (Steger et al. 1993;
Gems and Partidge 2001). 
Another growth factor possibly implicated in the increased longevity
of CF is transforming growth factor-beta (TGF-β), a crucial regulator of
cellular homeostasis, which has been recently shown to be also involved
in the regulation of cellular lifespan. In particular, it has been shown that
stress-induced premature senescence is mediated via TGF-β (Frippiat et
H. Pratsinis and others
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FIGURE 1: In vitro proliferative life-span of Cushing’s syndrome patients’ fibroblasts. CF and NF were
cultured until they reached replicative senescence. The values represent the cumulative population
doublings achieved by each strain. The horizontal bars indicate the median value for each group; p
was estimated by using the non-parametric Mann and Whitney rank sum test. Reproduced from
Pratsinis et al. (2002) Exp Gerontol 37: 1237-1245, with permission from Elsevier.
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al. 2001). The levels of TGF-β secreted by Cushing’s and normal fibrob-
lasts were measured, by using a highly sensitive and specific bioassay. In
particular, conditioned media (CM) from these cell strains were collect-
ed, and the amount of total and active TGF-β secreted was estimated. In
agreement with the extended lifespan of CF, these cells secrete lower lev-
els of active TGF-β in their milieu (Pratsinis et al. 2002), and – maybe,
more importantly – the average active TGF-β as a percentage of the total
is significantly lower in CF than in NF (Table 3). In addition, as reactive
oxygen species (ROS) have been inversely related with cellular longevity
and ageing in general (Finkel and Holbrook 2000), the internal ROS
content in both CF and NF was estimated, after incubation of the cells
with the fluorescent substrate DCFH-DA. Although no significant differ-
ence between the two groups was found (Table 3), there was a trend for
a lower concentration of ROS in CF compared to NF, as expected con-
sidering the increased longevity of CF. 
RESPONSE OF FIBROBLASTS FROM CUSHING’S SYNDROME PATIENTS
TO EXOGENOUS STRESS
It has been long suggested that longevity is inversely linked to stress
resistance. In particular, the expression of Heat Shock Proteins (HSP), a
group of molecular chaperones, is reduced during in vivo and in vitro age-
ing (Gutsmann-Conrad et al. 1998; Luce and Cristofalo 1992). It was dis-
covered that HSP70 basal levels (in the absence of any stress application)
of CF are relatively lower than that of NF (Pratsinis et al. 2002). After
induction with sodium arsenite, a known stressor, the levels of HSP70 lev-
els are dramatically increased in both cell types. However, while the per-
centage of activation for NF was 4.5-fold (over basal levels), in Cushing’s
syndrome-patients’ fibroblasts an approx. double activation, i.e. 10.7-fold
(Table 3) was observed. This highly enhanced response of CF is in agree-
ment with their extended lifespan in culture.
Stress hormones and fibroblast longevity
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TABLE 3: Parameters of Stress Resistance and Longevity in Cushing Fibroblasts
CF NF p
Active TGF-β1 secretion 32.5 (± 4.1) 42.9 (± 5.5) 0.004
(% of total TGF-β1)
Reactive oxygen species content 262.5 (±18.2) 363.6 (±45.9) 0.090
DCFH-DA fluorescence (A.U./ 103 cells)
HSP70 induction by sodium arsenite 10.7 (± 1.8) 4.5 (± 1.3) 0.007
Western analysis (-fold induction)
TGF-β1 secretion, and HSP70 inducibility of CF and NF cultures were studied as described in
detail elsewhere (Pratsinis et al. 2002). Reactive oxygen species was estimated as described in
Athanasas et al. (2004). Median values (± standard error) for each group (n=6) are presented; p was
estimated by using the non-parametric Mann and Whitney rank sum test. Adapted from Pratsinis et
al. (2002) Exp Gerontol 37: 1237-1245, with permission from Elsevier.
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CONCLUSIONS
Intense stresses are known to be detrimental for tissue homeostasis
and furthermore they may also accelerate the ageing process. At the cel-
lular level such a stress can provoke modifications in its structure and
function, e.g. in its redox status, protein metabolism and stability, DNA
synthesis, etc. (Rattan et al. 2004). Moreover, these stresses affect cellular
longevity. Probably, the best example in this direction is the application
of an exogenous oxidative stress. When early-passage cells are exposed to
sublethal concentrations of H2O2 or tert-butylhydroperoxide they enter a
permanent arrested state. This phenomenon is called “stress-induced
premature senescence” (SIPS) (Toussaint et al. 2000), as these cells
resemble those that have undergone senescence after serial subculturing
in vitro. In addition, SIPS is provoked when cells are exposed in hyperox-
ic conditions, i.e. a 40% oxygen partial pressure, compared to the stan-
dard condition of 20%. Finally, when cells are cultured under hypoxic
conditions (3% oxygen tension) or in the presence of free radical scav-
engers a considerable extension in their lifespan is observed (Toussaint
et al. 2002). In contrast to the above, it has been shown that exposure to
mild stress can counteract the negative effects of ageing (Minois 2000).
Several types of stress can provoke this anti-ageing effect, e.g. calorie
restriction, temperature shock, hypergravity, exercise or irradiation. In a
series of studies, Rattan and collaborators have shown that repeated mild
heat stress (exposure to 410C for 1h twice a week) has anti-ageing effects.
In particular, this treatment reduces the accumulation of oxidatively and
glycoxidatively damaged proteins, stimulates the proteasomal activities
for the degradation of abnormal proteins, enhances the cellular antioxi-
dant ability and its resistance to other stresses (Rattan et al. 2004). Calorie
restriction represents another type of mild stress. When rodents were fed
with a balanced diet containing approx. 30% less calories, they were
found to live significantly longer that the control – ad libitum fed-mice
(Masoro 2000). A similar lifespan extension was found also in fibroblasts
derived from these animals (Pendergrass et al. 1995). All these examples
collectively indicate that repeated mild stress can have beneficial and
even life promoting effect, a phenomenon called “hormesis” (Calabrese
and Baldwin 2000).
At the organismal level, systemic responses to stress are of primary
importance, as they affect nearly all tissues. In this context the activation
of the hypothalamic-pituitary-adrenal (HPA) axis, one of the immediate
hormonal responses to stress, is crucial for the maintenance of tissue
homeostasis. Cortisol hypersecretion, as a result of this activation, has
clearly a life-sustaining role. However, due to several side-effects, chronic
exposure to pharmacological doses of glucocorticoids (GC) can be detri-
mental for almost all tissues and even lead to accelerated ageing
H. Pratsinis and others
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(Boumpas et al. 1993; Sapolsky 1996; Boscaro et al. 2001). Cushing’s syn-
drome, a rare disease due to cortisol overproduction by the adrenal
glands, represents a good model for studying the cumulative effects of
GCs, since patients with this syndrome are exposed in excessive albeit
non-pharmacological doses of cortisol for a long period of time, in the
absence of an exogenous stress, and consequently they have an elderly-
like skin (atrophic and with impaired wound healing) due to the cata-
bolic effects of cortisol. Interestingly, Cushing’s syndrome fibroblasts,
when removed from the high-GC milieu of in vivo and cultured in vitro
under standard conditions, were found to restore their ability for colla-
gen synthesis and to secrete reduced levels of metalloproteases (MMP-1
and MMP-2). Even more, these cells are more vivid in culture than those
derived from normal, control donors, as they proliferate faster, they reach
higher final culture densities and they have increased contractile ability,
all important parameters for the maintenance of tissue homeostasis and
a proper wound healing process. Although it has been reported that glu-
cocorticoids can accelerate the ageing process, the data from the in vitro
phenotype of CF are pointing to an opposite direction, having in mind
that senescent cells lose their ability for proliferation, collagen synthesis
and contraction, while they secrete increased amounts of metalloproteas-
es. In agreement, it has been found that Cushing’s fibroblasts have a
remarkable extension of their lifespan in vitro. Furthermore, it has been
shown that CF produce less reactive oxygen species and secrete less TGF-
β, two factors that have been inversely related to senescence. More impor-
tantly, they are able to respond much better to exogenous stress, by pro-
ducing nearly double concentrations of inducible HSP70.
As mentioned above, one of the best examples of an extension of lifes-
pan as a result of a long-lasting mild stress is the case of calorie-restricted
rodents. Reduction of food intake markedly increases their longevity,
retards age-associated physiological decline and delays age-associated dis-
eases (Masoro 2000). Furthermore, calorie restriction leads to increased
replicative lifespan, cell proliferation and improved wound repair in vivo
and in vitro (Pendegrass et al. 1995; Wolf et al. 1995; Reed et al. 1996).
Interestingly, in an analogy to Cushing’s syndrome these animals exhibit
mildly elevated plasma glucocorticoid levels (Sabatino et al. 1991).
Another well known paradigm of hormesis is exercise. This activity
although stressful and deleterious in biochemical terms – due to the pro-
duction of free radicals and stress hormones (Rattan 2005) – has clearly
beneficial effects. Interestingly, plasma cortisol was found to be higher in
athletes, in agreement with their lower anabolic/ catabolic balance
(Grasso et al. 1997).
In conclusion, the data from the in vitro behaviour of Cushing’s syn-
drome fibroblasts indicate that a long-term exposure to high cortisol con-
centrations in vivo is not associated with persisting adverse changes in
Stress hormones and fibroblast longevity
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skin fibroblasts and/or acceleration of the aging process of these cells.
Instead, an unexpectedly positive effect on the physiology of these cells
when cultured in vitro has been found, as well as an extension of their
lifespan. Further work is needed to explain these anti-ageing effects of
the exposure to elevated cortisol concentrations. One possible explana-
tion for this phenomenon can be grounded on the ability of cortisol to
control metabolism. It has been hypothesized that optimal allocation of
metabolic resources between the maintenance and repair and other func-
tions is crucial for a proper somatic maintenance and for maximizing
longevity (Kirkwood and Franceschi 1992). Accordingly, the catabolic
action of cortisol leads to severe alterations in tissue homeostasis in
Cushing’s syndrome patients, such as dermal atrophy and impaired
wound repair. However, when these cells are removed from the high-cor-
tisol milieu they express in vitro an “anabolic” phenotype (characterised
by increased proliferation, collagen accumulation or contraction) and an
extension of their lifespan. This “hormetic” reaction can provide a basis
for understanding the beneficial effect of several stresses at the organis-
mal level.
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